Fierce Pharma

APRIL 19, 2023

Alnylam, Intra-Cellular among analyst's top picks for M&A as biopharma dealmaking heats up aliu Wed, 04/19/2023 - 14:39

Biopharma 228

Biopharma 228

Fierce Pharma

MAY 18, 2023

The Top Line': 2023's biopharma layoffs, plus this week's headlines tcarey Thu, 05/18/2023 - 16:13

Biopharma 144

Biopharma 144

Fierce Pharma

MAY 9, 2023

We want your stories: Biopharma's collective memory of COVID—in photographs aliu Tue, 05/09/2023 - 14:56

Biopharma 144

Biopharma 144

Fierce Pharma

DECEMBER 21, 2022

Tamiflu generics in short supply in latest chapter of biopharma's shortage saga. fkansteiner. Wed, 12/21/2022 - 08:40.

Biopharma 225

Biopharma 225

Fierce Pharma

SEPTEMBER 17, 2022

AbbVie and BMS slash 360 jobs in California, the latest in a streak of biopharma layoffs. fkansteiner. Fri, 09/16/2022 - 13:34.

Biopharma 300

Biopharma 300

Fierce Pharma

DECEMBER 20, 2022

2023 forecast: An 'inflection point' for biopharma, fueled by a flood of AI and machine learning products. Tue, 12/20/2022 - 13:39.

Biopharma 261

Biopharma 261

European Pharmaceutical Review

APRIL 17, 2023

A report on automation in the biopharma industr y has shown that the market is projected to grow at a compound annual growth rate (CAGR) of 5.7 Factors impacting the automation in the biopharma industry market The report found that 75 percent of pharmaceutical organisations want to use automated solutions more frequently.

Biopharma 87

Biopharma Pharmaceutical Pharmaceutical products Manufacturing 87

MedCity News

MAY 9, 2023

Baxter International is selling its biopharma solutions business to private equity firms. The transaction is part of a broader trend in which life science firms are spinning out or selling operations in order to hone the focus of the remaining business on certain areas.

Biopharma 114

Biopharma Sales Pharma 114

PharmaVoice

MAY 23, 2023

These genetic advances could play a part in our biopharma future. Ancient DNA from a deer tooth. A new way to connect genes with disease. Biological super-computing.

Biopharma 98

Biopharma 98

MedCity News

MAY 11, 2023

Swedish Orphan Biovitrum is acquiring CTI Biopharma in a $1.7 billion deal centered on the biotech’s commercialized drug for the blood cancer myelofibrosis. Sobi says the drug, Vonjo, complements one of its own assets approved for a different blood disorder.

Biopharma 104

Biopharma Pharma 104

PharmaTech

JUNE 1, 2023

A partnership between Rentschler Biopharma and Ikarovec will support the accelerated development of novel gene therapies for the treatment of eye diseases.

Biopharma 69

Biopharma 69

Pharmaceutical Technology

JUNE 2, 2023

Rentschler Biopharma has collaborated with Ikarovec for expediting the new gene therapies to treat ophthalmic disease. Under the deal, Rentschler Biopharma’s ATMP facility in Stevenage, UK, will undertake the bioprocess development of adeno-associated virus (AAV) material.

Biopharma 52

Biopharma Pharmaceutical Manufacturing Patients 52

Fierce Pharma

JANUARY 23, 2023

Call for nominations: The most influential people in biopharma in 2023 esagonowsky Mon, 01/23/2023 - 14:32

Biopharma 130

Biopharma 130

Pharmaceutical Technology

FEBRUARY 28, 2023

Breakthroughs in therapies containing monoclonal antibodies (mAbs) are showing ever-greater potential in treating a range of diseases, alongside biopharma manufacturers facing the challenge of keeping up with demand for production while controlling costs. This can result in reductions in costs for our customers.” Download to learn more.

Biopharma 94

Biopharma Manufacturing Training Pharmaceutical 94

Pharmaceutical Technology

MAY 26, 2023

HanAll Biopharma and Daewoong Pharmaceutical have entered into a co-development deal with NurrOn Pharmaceuticals to develop therapy for Parkinson’s disease (PD) and other neurodegenerative disorders. By activating Nurr1, ATH-399A slows disease progression in PD patients.

Biopharma 52

Biopharma Pharmaceutical Patients Medicine 52

European Pharmaceutical Review

MARCH 31, 2023

Impact of SVB UK acquisition on European biopharma companies One Netherlands-based biopharmaceutical company anticipated that the acquisition of SVP UK would allow access to its $19 million deposit and not experience losses, noted GlobalData.

Biopharma 87

Biopharma Pharma Pharmaceutical Medicine 87

Fierce Pharma

NOVEMBER 22, 2022

2023 preview: Despite Biden's drug pricing win, the biopharma industry is not 'anywhere near done with this conversation'. esagonowsky. Tue, 11/22/2022 - 14:22.

Biopharma 130

Biopharma 130

Pharmaceutical Technology

MAY 10, 2023

Swedish Orphan Biovitrum (Sobi) has entered into a definitive agreement to buy biopharmaceutical company CTI BioPharma in an all-cash deal valued at $1.7bn. Sobi will start a tender offer through its wholly owned indirect subsidiary to buy all outstanding CTI shares for $9.10 for each share of common stock in cash.

Biopharma 59

Biopharma Food and Drug Administration Medicine Patients 59

Pharma Leaders

APRIL 28, 2023

Swedish biotech company Hansa Biopharma has entered a research and development collaboration with Genethon. The partnership will assess the efficacy and safety of imlifidase, Hansa Biopharma’s antibody cleaving enzyme, in a clinical trial.

Biopharma 52

Biopharma Patients Medicine Safety 52

Pharmaceutical Commerce

APRIL 21, 2023

In this latest Harvard Business School Healthcare Alumni Association Q&A, Dr. Peter Cappelli, Professor of Management at The Wharton School and Director of Wharton’s Center for Human Resources, explains how biopharma C-suites can lead their teams through 2023’s turbulent times.

Biopharma 52

Biopharma Healthcare Healthcare Leads 52

European Pharmaceutical Review

OCTOBER 18, 2022

A study published in Drug Discovery Today found that although outsourcing of biopharma R&D offers productivity benefits, near-term gains can be offset by slower innovation over the long term. Trends in biopharma contract manufacturing 2022. .

Biopharma 80

Biopharma Pharmaceutical Competition Manufacturing 80

PharmaVoice

NOVEMBER 21, 2022

Biopharma IPOs have puttered in 2022, particularly compared to the record-breaking previous year, but they might be set to rebound.

Biopharma 105

Biopharma 105

PharmaVoice

APRIL 27, 2023

Events over the last year, including Pfizer’s Seagen buy and AstraZeneca’s CinCor deal, have foreshadowed the comeback of biopharma M&A.

Biopharma 52

Biopharma 52

Pharmaceutical Technology

MARCH 22, 2023

The appeal of process intensification continues to grow in the biopharma industry as a means of not only increasing the productivity, but also improving sustainability. Chromatography and clarification play vital parts in biopharma manufacturing, yet there is room for improvement in processes to eliminate inefficiencies and increase yield.

Biopharma 52

Biopharma Manufacturing Patients Pharma 52

PharmaVoice

MAY 4, 2023

A number of biopharma companies slashed their workforces this year and as market anxieties persist, more challenges could be looming.

Biopharma 52

Biopharma Marketing 52

Pharmaceutical Technology

OCTOBER 4, 2022

The post Pfizer acquires biopharma firm Biohaven for $11.6bn appeared first on Pharmaceutical Technology. “Combined with Pfizer’s global reach, this acquisition increases our potential to bring new treatment options to patients with migraine – a disease which affects over one billion people worldwide.”.

Biopharma 106

Biopharma Food and Drug Administration FDA Pharmaceutical 106

MedCity News

NOVEMBER 14, 2022

These platforms need to replace traditional data management methods and workflows for biopharma companies and contract development and manufacturing organizations that seek competitive advantages. Cloud-based data management solutions help the industry meet its business and compliance challenges.

Biopharma 90

Biopharma Management Manufacturing Competition 90

pharmaphorum

DECEMBER 15, 2022

Skin health-focused biopharma Almirall announced a CEO shakeup early in November, with Gianfranco Nazzi stepping down “to pursue new professional opportunities”. Bungay formerly served as CEO of Chroma Therapeutics and COO of Mereo Biopharma. Other biopharma hires. He will take over from interim CEO Sergio Marullo di Condojanni.

Biopharma 52

Biopharma Pharma Medicine Medical 52

PharmExec

MARCH 13, 2023

Sumitovant Biopharma has completed its acquisition of Myovant Sciences in an all-cash deal worth $1.7 billion, with Myovant being delisted from the New York Stock Exchange and its shares no longer publicly traded.

Biopharma 52

Biopharma 52

Pharma Leaders

MARCH 13, 2023

Following the completion of The post Sumitovant Biopharma completes acquisition of Myovant Sciences appeared first on Pharmaceutical Business review. The deal was announced on 23 October 2022. Sumitovant has acquired all outstanding shares of Myovant it did not own through the all-cash deal.

Biopharma 52

Biopharma Pharmaceutical 52

Pharmaceutical Technology

JANUARY 24, 2023

BioCryst Pharmaceuticals is collaborating with Swixx BioPharma for Orladeyo (berotralstat) commercialisation in Central and Eastern Europe (CEE). Under the deal, Swixx BioPharma will handle the commercialisation activities of oral therapy in 15 CEE markets.

Biopharma 52

Biopharma Pharmaceutical Patients Marketing 52

Pharmaceutical Technology

JULY 29, 2022

As the full consequences of the COVID-19 virus started to emerge, and many industries found themselves having to either suspend operations or move to remote working, the biopharma sector found itself on the front line facing unprecedented challenges. R&D ecosystem - Index score 6.54/10.

Biopharma 59

Biopharma Pharmaceutical Manufacturing Pharmaceutical manufacturing 59

PharmaTech

MAY 17, 2023

Context surrounding the Inflation Reduction Act is necessary for a comprehensive understanding of the global biopharma market.

Biopharma 52

Biopharma Marketing 52

Pharmaceutical Technology

JANUARY 20, 2023

Nevertheless, the potential for mAb therapies in treating medical conditions that have limited options means that biopharma companies are investing considerable resources in development. The post Overcoming challenges with scalability in biopharma manufacturing appeared first on Pharmaceutical Technology. Download to learn more.

Biopharma 52

Biopharma Manufacturing Patients Pharmaceutical 52

Pharmaceutical Technology

SEPTEMBER 8, 2022

The post Roche to acquire biopharma firm Good Therapeutics for $250m appeared first on Pharmaceutical Technology. In August, the company entered a strategic partnership and licence agreement with Poseida Therapeutics for developing allogeneic CAR-T cell therapies for hematologic malignancies.

Biopharma 111

Biopharma Patients Pharma Pharmaceutical 111

PharmaVoice

MAY 4, 2023

With leaders at the biggest biopharma companies bringing in millions, the CEO of Corvus Pharmaceuticals opted for a pay cut to pour more funds into science.

Biopharma 59

Biopharma Pharmaceutical 59

PharmaTech

AUGUST 2, 2022

Successful digital transformation in biopharma requires an integrated approach to the data lifecycle.

Biopharma 98

Biopharma 98